CEO Amir Reuveny told Built In that the company is in talks with the FDA to obtain clearance and that the device should be out by 2021.

It comes in the form of a patch that fits on the user’s torso and is worn over several nights, measuring things like respiratory effort, oxygen levels, heart rate and movement. This data is then sent over to a sleep professional who can help interpret the data, make a possible diagnosis and offer treatment options.